InsidersTradesSigma
Explore the full record of transactions filed by Plesha Scott M., Chief Executive Officer. Insider active across 2 companies, notably Pelthos Therapeutics Inc.. In total, 5 disclosures have been published. The latest transaction was filed on 2 July 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
5 of 5 declarations
Scott M. Plesha is the CEO and President of Pelthos Therapeutics Inc. and BioDelivery Sciences International Inc. In these roles, he is responsible for the strategic and operational direction of the companies, which focus on developing innovative therapies. Mr. Plesha plays a crucial role in setting growth objectives and overseeing daily operations.